loader2
Partner With Us NRI

Jenburkt Pharmaceuticals Ltd share Price Today

Company details

683.40
702.00
586.90
925.00
6M Return 0.54%
1Y Return 0.20%
Mkt Cap.(Cr) 304.50
Volume 3,530
Div Yield 2.06%
OI
-
OI Chg %
-
Volume 3,530

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Jenburkt Pharmaceuticals Ltd shares SWOT Analysis

Strengths (7)

  • Effectively using its capital to generate profit - RoCE improving in last 2 years
  • Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
  • Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Weakness (3)

  • Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
  • Declining Net Cash Flow : Companies not able to generate net cash
  • Weak Momentum: Price below Short, Medium and Long Term Averages

Opportunity (0)

Data not found

Threats (4)

  • Promoter decreasing their shareholding
  • Companies with growing costs YoY for long term projects
  • Increasing Trend in Non-Core Income

Resistance and support

R1 719.3
R2 739.7
R3 766.8
Pivot

692.17

S1 671.8
S2 644.7
S3 624.3
EMA SMA
728.3
749.0
742.0
721.4
736.3
785.4
736.6
721.0
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
JENBURKT PHARMACEUTICALS LTD Bulk Purchase 2023-01-06 649.97 47037 BSE
ARIES STOCKTRADES PVT LTD A/C-PMS Bulk Sell 2020-08-25 410.39 26000 BSE
KETAN JAYANTILAL KARANI (HUF) Bulk Purchase 2018-02-08 540.5 26000 BSE
Name Category Shares
JAYSHREE UTTAM BHUTA PROMOTER 12.16%
KALINDI HEMENDRA BHUTA PROMOTER 9.06%
ASHISH UTTAM BHUTA PROMOTER 5.92%
MAHESH H BHUTA PROMOTER 1.54%
BHAVIKA ASHISH BHUTA PROMOTER 1.17%
KUNTI KETAN GALA PROMOTER 1.16%
RIDDHI HARESH SHROFF PROMOTER 0.73%
PRAKASH H BHUTA PROMOTER 0.67%
JAGRUTI KETAN BHUTA PROMOTER 0.65%
BHUTA HOLDINGS PRIVATE LIMITED PROMOTER 13.96%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Jenburkt Pharmaceuticals Ltd Stocks COMPARISON

Financials( in Cr) Jenburkt Pharmaceuticals Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Dr Reddys Laboratories Ltd Zydus Lifesciences Ltd
Price 690.00 1,628.90 1,512.90 6,195.25 1,012.90
% Change -1.29 1.54 3.39 2.50 1.32
Mcap Cr 304.50 390,827.68 122,143.98 103,342.35 102,526.14
Revenue TTM Cr 136.75 43,885.68 15,790.60 24,669.70 17,237.40
Net Profit TTM Cr 24.61 8,560.84 2,513.47 4,507.30 1,997.30
PE TTM 12.62 41.13 29.93 19.30 30.34
1 Year Return 0.20 65.63 70.12 38.11 110.19
ROCE 26.04 16.79 14.76 25.99 16.25
ROE 20.53 16.46 10.66 21.21 14.05
INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 122.39 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 30,755.54 31,723.05
LAST 3M 69,913.40 26,515.65
LAST 6M 130,081.93 60,306.69
LAST 12M 189,259.39 205,003.99

Jenburkt Pharmaceuticals Ltd Information

Stock PE (TTM)
12.62
Promoter Holding
47.39%
Book Value
295.4882
ROCE
26.04%
ROE
20.53%
Description
  • Jenburkt Pharmaceuticals Ltd, incorporated in 1985, was formed a venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family. The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries. It has more than 1,000 stockists and their reach extends to 400,000 pharmacies across the globe. The organisation caters to government, semi-government institutions, missionary hospitals, public sector enterprises, etc. Apart from this. the Company operate manufacturing plant at Sihor-Gujarat, approved as per W.H.O (World Health Organisation) guidelines with current Good Manufacturing Practices (GMP) requirements. In addition, it has a Research & Development unit duly approved by the Ministry of Science & Technology, Government of India. Hence, the Company has strong manufacturing facilities to cater to domestic and international market. The purpose of the Company is to serve those in need of quality healthcare by bringing revolutionary, life-changing therapeutic solutions that are accessible to all. Way back in the 20th century, a visionary in the field of healthcare and philanthropic work - Shri Nandlal Mulji Bhuta laid the foundation for several groups of companies. Continuing the legacy of Shri Nandlal Mulji Bhuta, his sons Mr. Uttam N. Bhuta and Mr. Hemendra N. Bhuta founded the Company. In 2021-22, the Company launched a new OTC division ~ Jenburkt Wellness towards better physical and mental health. The first brand launched was Zixa Strong, natural, pain relief product. Further, it launched Nervijen D3 tablets in 2022-23.

Registered Address

Nirmala Apartment P B No 37396, 93 Jayprakash Road Andheri(W), Mumbai, Maharashtra, 400058

Tel : 91-22-66943121/67603603
Email : investor:jenburkt.com
Website : http://www.jenburkt.com
Registrar

Bigshare Services Pvt Ltd

AGM Date (Month) : Jul
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524731
NSE Code :
Book Closure Date (Month) : Jul
BSE Group : X
ISIN : INE354A01013

FAQ’s on Jenburkt Pharmaceuticals Ltd Shares

You can buy Jenburkt Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Jenburkt Pharmaceuticals Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Mar 28, 2024 02:59 PM the closing price of Jenburkt Pharmaceuticals Ltd was ₹ 690.00.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Mar 28, 2024 02:59 PM, the market cap of Jenburkt Pharmaceuticals Ltd stood at ₹ 304.50.

The latest PE ratio of Jenburkt Pharmaceuticals Ltd as of Mar 28, 2024 02:59 PM is 12.62

The latest PB ratio of Jenburkt Pharmaceuticals Ltd as of Mar 28, 2024 02:59 PM is 0.42

The 52-week high of Jenburkt Pharmaceuticals Ltd share price is ₹ 925.00 while the 52-week low is ₹ 586.90

Download Our

Download App
market app